tiprankstipranks
Molecular Partners (MOLN)
NASDAQ:MOLN
US Market
MOLN
Molecular Partners
RESEARCH TOOLSreports
Want to see MOLN full AI Analyst Report?

Molecular Partners (MOLN) Stock News & Sentiment

46 Followers
Molecular Partners Starts Dosing DLL3 Radio-DARPin MP0712, Highlights Program at ASCO and SNMMI 2026
Premium
Company Announcements
Molecular Partners Starts Dosing DLL3 Radio-DARPin MP0712, Highlights Program at ASCO and SNMMI 2026
5h ago
6K
MOLN
Molecular Partners: Buy Rating Reaffirmed on Pipeline Progress and Cash Runway, $12 Price Target Unchanged
Premium
Ratings
Molecular Partners: Buy Rating Reaffirmed on Pipeline Progress and Cash Runway, $12 Price Target Unchanged
20d ago
MOLN
Molecular Partners Advances Radio-DARPin and Immuno-Oncology Pipeline on Solid Financial Footing in Q1 2026
Premium
Company Announcements
Molecular Partners Advances Radio-DARPin and Immuno-Oncology Pipeline on Solid Financial Footing in Q1 2026
20d ago
6K
MOLN
Molecular Partners Showcases Nature Cancer Phase 1 Data and Advances MP0317 Into Phase 2 Cholangiocarcinoma Trial
Premium
Company Announcements
Molecular Partners Showcases Nature Cancer Phase 1 Data and Advances MP0317 Into Phase 2 Cholangiocarcinoma Trial
1M ago
6K
MOLN
Molecular Partners: Unmodeled Upside from MP0632 AND-Gate T Cell Engager Supports Buy Rating and $13 Target
Premium
Ratings
Molecular Partners: Unmodeled Upside from MP0632 AND-Gate T Cell Engager Supports Buy Rating and $13 Target
1M ago
MOLN
Molecular Partners Adds Deal Veteran to Board as Shareholders Back All AGM Proposals
Premium
Company Announcements
Molecular Partners Adds Deal Veteran to Board as Shareholders Back All AGM Proposals
2M ago
6K
MOLN
Molecular Partners Sets 2026 AGM, Nominates Clare Fisher to Board as Long-Serving Director Steps Down
Premium
Company Announcements
Molecular Partners Sets 2026 AGM, Nominates Clare Fisher to Board as Long-Serving Director Steps Down
2M ago
6K
MOLN
More MOLN News >

MOLN News on the Web

Molecular Partners to hold trial-in-progress presentations on Phase 1/2a study
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)
TipRanks News
Bullish
Molecular Partners: Buy Rating Reaffirmed on Pipeline Progress and Cash Runway, $12 Price Target Unchanged
TipRanks News
Bullish
Molecular Partners Advances Radio-DARPin and Immuno-Oncology Pipeline on Solid Financial Footing in Q1 2026
TipRanks News
Neutral
Molecular Partners Showcases Nature Cancer Phase 1 Data and Advances MP0317 Into Phase 2 Cholangiocarcinoma Trial
TipRanks News
Neutral
Molecular Partners publishes MP0317 clinical data in Nature Cancer
TipRanks News
Bullish
Molecular Partners: Unmodeled Upside from MP0632 AND-Gate T Cell Engager Supports Buy Rating and $13 Target
TipRanks News
Bullish
Molecular Partners announces presentation of preclinical data at AACR
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
MOLN
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average82%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MOLN’s Media Buzz Sentiment?
1 articles about MOLN were published this week. In an average week, 1.25 articles are published.
    What is MOLN’s weekly average amount of articles?
    In an average week, 1.25 articles about MOLN are published.
      What is MOLN’s News Sentiment?
      100% of articles about MOLN were positive this week, compared to its sector average of 82%.
        Healthcare Stocks that are Trending in the News
        AAgilent
        PHRPhreesia
        ADOAnteoTech Ltd
        OTLKOutlook Therapeutics
        IHHHFIHH Healthcare Bhd
        Showing the stocks with the most bullish news sentiment over the past week